Last reviewed · How we verify
Crinone 8% Vaginal Gel
At a glance
| Generic name | Crinone 8% Vaginal Gel |
|---|---|
| Also known as | IVF-ET, Pregnancy, luteal phase support, Crinone, Intramuscular progesterone |
| Sponsor | Centrum Clinic IVF Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (PHASE3)
- Randomized Trial of Maternal Progesterone Therapy (PHASE2)
- Sexual Absorption of Vaginal Progesterone (PHASE4)
- An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) (PHASE3)
- Luteal Support in Frozen-Thawed Embryo Transfer Cycles (PHASE4)
- Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles (PHASE4)
- Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles (PHASE4)
- Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Crinone 8% Vaginal Gel CI brief — competitive landscape report
- Crinone 8% Vaginal Gel updates RSS · CI watch RSS
- Centrum Clinic IVF Center portfolio CI